to contribute to well-being of humanity by treating chronic immune diseases through peptide drugs we discover and develop.
Thank you for visiting our website.
KINE SCIENCES is a company that develops ultra-small peptide innovative medicines
based on functional immunomics.
We discovered the function of a novel cytokine ERDR1 for the first time in the world
and since we have been developing drug candidates of ultra-small peptide with private
and public funding including the one from Korea Drug Development Fund for
consecutive four years.
The diseases we aim to treat are chronic immune diseases such as rheumatoid arthritis,
inflammatory bowel diseases, atopic dermatitis, psoriasis, cancer, Alzheimer’s disease,
and many rare immune diseases.
Though we live in an era when we see more research on life sciences and more drugs
on the market than any other era of human history, we humans have yet to find cures
for these chronic immune diseases by seeing occurrence of resistance or relapse which
make lifelong treatment of expensive medicines inevitable for patients.
These diseases put a great burden not only on patients themselves but their families
and the society as a whole.
KINE SCIENCES is committed to treating chronic immune diseases, making lives of
patients and their families better, and ultimately improving well-being of humanity by
developing safer, more economical and more convenient medicines of ultra small
peptides.
Please give us encouragement and support for our daunting journey.
Dae Ho Cho Ph.D
Ph.D, Chicago Medical School; B.S., SUNY
Professor of Convergence Research Institute, Korea University
Head of Nano Bio material Research Center, Korea University
Professor of Department of Life Sciences, Sookmyung Women's University
M.S, Business Administration, Sogang University, Bachelor of Pharmacy, Seoul National University
Senior Vice President, Head of Clinical Science Division & Regulatory Affairs Team, Samsung Bioepis
Vice President, Strategic Business Development, Samsung Electronics
Executive Director, Head of Market Access Division & Compliance, Novartis, Pharma
Manager, Regulatory Affairs, Baxter
B.S., Business Administration, Korea University
CFO and COO of Hanel
CFO of Meere Company
CPA of Samil PwC
M.S, Business Administration, Korea University
Vice President of Strategic Planning & BD, NKMAX
General Manager of M&A, Samsung Fire & Marine
Project Manager, A.T.Kearney
Consultant, Accenture
Ph.D & B.S, Korea University
Research Professor of Institute of Convergence Science, Korea University
Research Professor for BK21PLUS Project, Korea University
Senior Researcher, Sookmyung Women’s University
Ph.D, Chungnam National University; M.S. & B.S. Kangwon National University
Assistant Professor of Anatomy Class of Medical School, Injae University
B.S., M.S, & Ph.D, Department of Cell Biology, Sookmyung Women's University
Senior Researcher, Sookmyung Women's University
Senior Researcher, SIS Immunology Research Center, Sookmyung Women's University
Research Professor, Sookmyung Women’s University
B.S., Hankuk University of Foreign Studies Ph.D., Hallym University
Instructor, Massachusetts General Hospital and Harvard Medical School
Senior Scientist, Walden Biosciences
Core Value